* Streamline Health Solutions Inc STRM.OQ STRM.O is
expected
to show a rise in quarterly revenue when it reports results on
September 7.
* The Alpharetta Georgia-based company is expected to
report a
81.4% increase in revenue to $5.203 million from $2.87 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Streamline Health
Solutions Inc is for a loss of 7 cents per share. For the same
quarter last year, the company reported breakeven results per
share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Streamline
Health
Solutions Inc is $3, above its last closing price of $1.51.
This summary was machine generated September 5 at 20:25 GMT.
All figures in US dollars unless otherwise stated